ESOR Special Focus Series
Mental Health Imaging
Lectures
Epidemiology of psychiatric diseases WHO report
30:00Jean-Pierre Pruvo
Current indications in mental health imaging and the future of imaging biomarker design
30:00Lotfi Hacein-Bey
Applications of MRI in psychiatric disease, especially the first psychotic event
30:00Riyad Hanafi
Brain imaging in severe and complex psychiatric disorders
30:00Ali Amad
Applications of AI in normal aging and psychiatry: ready for useful biomarkers
30:00Loukas Astrakas
Implementation of one day-care imaging center of mental health diseases
30:00Su Lui
Functional connectivity in bipolar disorders
30:00Sidney Krystal
Imaging and care of hallucinations
30:00Renaud Jardi
Mapping psychiatric diseases through ethical AI
30:00Arnaud Attye
Neuromodulation in psychiatric disease: current indications, and experience
30:00Leo Sugrue
Novel interventions in addictions and ADHD: DBS and other
30:00Jody Tanabe
COURSE INFORMATION
Mental health disorders account for a significant amount of health care expenditures, emotional suffering, economic loss and suicide throughout the world and across cultures. There is growing evidence that many mental health conditions are caused by treatable neurological ailments that can be diagnosed by currently available imaging techniques. More importantly, mental health disorders that are not currently detectable by anatomical imaging are increasingly and convincingly shown to result from faulty functional integration of cortical and subcortical neural networks, for which phenotypic functional connectivity signatures are defined with increasing precision, providing for useful imaging markers. Further and consequently, therapeutic targets and novel, creative treatment approaches are being increasingly defined so that mental health conditions that had so far no therapeutic option can now be managed successfully.
This course provides up-to-date evidence-based information on the current status of imaging-based assessment and treatment of mental health disorders.
LEARNING OBJECTIVES
- Understand the importance of mental health disorders in public health
- Learn about imaging-based assessment of mental health
- Learn about functional connectivity phenotypes in depression and other conditions
- Learn about novel interventions for mental health disorders
PROGRAMME ONLINE
Monday, November 10, 2025
| 11:00 – 11:30 | Epidemiology of psychiatric diseases WHO report Jean-Pierre Pruvo, Lille/FR |
| 11:30 – 12:00 | Current indications in mental health imaging and the future of imaging biomarker design Lotfi Hacein-Bey, Palo Alto, CA/USA; Alice Le Berre, San Francisco, CA/USA |
| 12:00 – 12:30 | Applications of MRI in psychiatric disease, especially the first psychotic event Riyad Hanafi, Lille/FR |
| 12:30 – 13:00 | Brain imaging in severe and complex psychiatric disorders Ali Amad , Lille/FR |
| 13:00 – 13:30 | Applications of AI in normal aging and psychiatry: ready for useful biomarkers Loukas Astrakas, Ioannina/GR |
| 13:30 – 14:00 | Implementation of one day-care imaging center of mental health diseases Su Lui, Chengdu/China |
| 14:00 – 14:30 | Q&A Session |
| 14:30 – 15:00 | Break |
| 15:00 – 15:30 | Functional connectivity in bipolar disorders Sidney Krystal, Paris/FR |
| 15:30 – 16:00 | Imaging and care of hallucinations Renaud Jardri, Lille/FR |
| 16:00 – 16:30 | Mapping psychiatric diseases through ethical AI Arnaud Attye, Grenoble/FR |
| 16:30 – 17:00 | Neuromodulation in psychiatric disease: current indications, and experience Leo Sugrue, San Francisco/USA |
| 17:00 – 17:30 | Novel interventions in addictions and ADHD: DBS and other Jody Tanabe, Denver/USA |
| 17:30 – 18:00 | Q&A Session |